Skip to main content

Animations

MJFF Publications

4951 - 4960 of 9030 Results
Title
Year
  • Year
  • 2022
  • 2016
  • 2020
  • 2022
  • 2014
  • 2019
  • 2024
  • 2022
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Genome Sequencing in the Parkinson Disease Clinic
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000193
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000711
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200008
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Course of psychiatric symptoms and global cognition in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-45692-3
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Hierarchical Denoising of Ordinal Time Series of Clinical Scores
    Journal Name: IEEE Journal of Biomedical and Health Informatics
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/jbhi.2022.3163126
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Genomics transformer for diagnosing Parkinson's disease
    Journal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Differences in brain aging between sexes in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00646-w
    Citation Count: 32
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.